S
Stefanie Engler
Researcher at University of Zurich
Publications - 16
Citations - 923
Stefanie Engler is an academic researcher from University of Zurich. The author has contributed to research in topics: Mass cytometry & Gene. The author has an hindex of 9, co-authored 14 publications receiving 580 citations. Previous affiliations of Stefanie Engler include ETH Zurich & University of Fribourg.
Papers
More filters
Journal ArticleDOI
Compensation of Signal Spillover in Suspension and Imaging Mass Cytometry.
Stéphane Chevrier,Helena L. Crowell,Helena L. Crowell,Vito R T Zanotelli,Stefanie Engler,Mark D. Robinson,Mark D. Robinson,Bernd Bodenmiller +7 more
TL;DR: This work describes a novel bead-based compensation workflow and R-based software that estimates and corrects for interference between channels that greatly simplifies the development of new antibody panels, increases flexibility for antibody-metal pairing, opens the way to using less pure isotopes, and improves overall data quality.
Journal ArticleDOI
Simultaneous Multiplexed Imaging of mRNA and Proteins with Subcellular Resolution in Breast Cancer Tissue Samples by Mass Cytometry.
Daniel Schulz,Vito R T Zanotelli,Jana R. Fischer,Denis Schapiro,Stefanie Engler,Xiao-Kang Lun,Hartland W. Jackson,Bernd Bodenmiller +7 more
TL;DR: Analysis of 70 breast cancer samples showed that HER2 and CK19 mRNA and protein levels are moderately correlated on the single-cell level, but that only HER2, and not CK19, has strong mRNA-to-protein correlation on the cell population level.
Journal ArticleDOI
A Map of Human Type 1 Diabetes Progression by Imaging Mass Cytometry
Nicolas Damond,Stefanie Engler,Vito R T Zanotelli,Denis Schapiro,Clive Wasserfall,Irina Kusmartseva,Harry S. Nick,Fabrizio Thorel,Pedro Luis Herrera,Mark A. Atkinson,Bernd Bodenmiller +10 more
TL;DR: Analysis of islets from 12 human donors using imaging mass cytometry revealed that β cell destruction is preceded by a β cell marker loss and by recruitment of cytotoxic and helper T cells in type 1 diabetes.
Journal ArticleDOI
HDAC1 and HDAC2 Control the Specification of Neural Crest Cells into Peripheral Glia
Claire Jacob,Pirmin Lötscher,Stefanie Engler,Stefanie Engler,Arianna Baggiolini,Sandra Varum Tavares,Valérie Brügger,Nessy John,Stine Büchmann-Møller,Paige Snider,Simon J. Conway,Teppei Yamaguchi,Patrick Matthias,Lukas Sommer,Ned Mantei,Ueli Suter +15 more
TL;DR: It is shown here that histone deacetylases 1 and 2 (HDAC1/2) are essential for the specification of neural crest cells into Schwann cell precursors and satellite glia, which express the early determinants of their lineage myelin protein zero and/or fatty acid binding protein 7.
Journal ArticleDOI
The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support
Anja Irmisch,Ximena Bonilla,Ximena Bonilla,Ximena Bonilla,Stéphane Chevrier,Kjong-Van Lehmann,Kjong-Van Lehmann,Kjong-Van Lehmann,Franziska Singer,Franziska Singer,Nora C. Toussaint,Nora C. Toussaint,Cinzia Esposito,Julien Mena,Emanuela S. Milani,Ruben Casanova,Daniel J. Stekhoven,Daniel J. Stekhoven,Rebekka Wegmann,Francis Jacob,Bettina Sobottka,Sandra Goetze,Jack Kuipers,Jack Kuipers,Jacobo Sarabia del Castillo,Michael Prummer,Michael Prummer,Mustafa Anil Tuncel,Mustafa Anil Tuncel,Ulrike Menzel,Andrea Jacobs,Stefanie Engler,Sujana Sivapatham,Anja Frei,Gabriele Gut,Joanna Ficek,Joanna Ficek,Joanna Ficek,Nicola Miglino,Melike Ak,Faisal Alquaddoomi,Jonas B. Albinus,Ilaria Alborelli,Sonali Andani,Per-Olof Attinger,Daniel Baumhoer,Beatrice Beck-Schimmer,Lara Bernasconi,Anne Bertolini,Natalia Chicherova,Maya D'Costa,Esther Danenberg,Natalie R. Davidson,Monica-Andreea Drăgan,Martin Erkens,Katja Eschbach,André Fedier,Pedro Ferreira,Bruno S. Frey,Linda Grob,Detlef Günther,Martina Haberecker,Pirmin Haeuptle,Sylvia Herter,René Holtackers,Tamara Huesser,Tim M. Jaeger,Katharina Jahn,Alva Rani James,Philip Jermann,André Kahles,Abdullah Kahraman,Werner Kuebler,Christian P. Kunze,Christian Kurzeder,Sebastian Lugert,Gerd Maass,Philipp Markolin,Julian M. Metzler,Simone Muenst,Riccardo Murri,Charlotte K.Y. Ng,Stefan Nicolet,Marta Nowak,Patrick G. A. Pedrioli,Salvatore Piscuoglio,Mathilde Ritter,Christian Rommel,María Lourdes Rosano-Gonzalez,Natascha Santacroce,Ramona Schlenker,Petra C. Schwalie,Severin Schwan,Tobias Schär,Gabriela Senti,Vipin T. Sreedharan,Stefan G. Stark,Tinu M. Thomas,Vinko Tosevski,Marina Tusup,Audrey Van Drogen,Marcus Vetter,Tatjana Vlajnic,Sandra Weber,Walter P. Weber,Michael Weller,Fabian Wendt,Norbert Wey,Mattheus H.E. Wildschut,Shuqing Yu,Johanna Ziegler,Marc Zimmermann,Martin Zoche,Gregor Zuend,Rudolf Aebersold,Marina Bacac,Niko Beerenwinkel,Niko Beerenwinkel,Christian Beisel,Bernd Bodenmiller,Bernd Bodenmiller,Reinhard Dummer,Viola Heinzelmann-Schwarz,Viktor H. Koelzer,Markus G. Manz,Holger Moch,Lucas Pelkmans,Berend Snijder,Berend Snijder,Alexandre Theocharides,Markus Tolnay,Andreas Wicki,Bernd Wollscheid,Gunnar Rätsch,Mitchell P. Levesque +134 more
TL;DR: The Tumor Profiler Study as mentioned in this paper is an observational trial combining a prospective diagnostic approach to assess the relevance of in-depth tumor profiling to support clinical decision-making with an exploratory approach to improve the biological understanding of the disease.